Raphael Pharmaceutical dismisses auditor Weinstein International, appoints Elkana Amitai CPA on short-term basis

Raphael Pharmaceutical Inc.

Weinstein International CPA dismissed as independent auditor effective September 5, 2024.
Prior auditor's reports for FY 2022 and 2023 contained a going concern qualification.
New auditor Elkana Amitai CPA engaged for quarter ending September 30, 2024, on a short-term basis.
No disagreements or reportable events occurred during the past two fiscal years and interim period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.